Relapsing Remitting Multiple Sclerosis: Clinical Trials

2 trials for Relapsing Remitting Multiple Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2

Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
NU100, Placebo, rhIFN beta-1b - Relapsing Remitting Multiple Sclerosis
Phase 3UnknownNuron Biotech Inc.5002011-10-012013-09-23
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
Simvastatin - Relapsing Remitting Multiple Sclerosis
Phase 3UnknownAlabama Neurology Associates, PC302005-10-012005-12-07

Narrower conditions

Multiple Sclerosis, Relapsing-Remitting (2)

Broader conditions

Autoimmune Diseases (2)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Demyelinating Autoimmune Diseases, CNS (2)  ·  Demyelinating Diseases (2)  ·  Immune System Diseases (2)  ·  Multiple Sclerosis (2)  ·  Nervous System Diseases (2)

Interventions

Simvastatin (1)

Sponsors

Alabama Neurology Associates, PC (1)  ·  Nuron Biotech Inc. (1)

Countries

Belarus (1)  ·  Bulgaria (1)  ·  Croatia (1)  ·  Georgia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Poland (1)  ·  Russia (1)  ·  Serbia (1)  ·  Spain (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Emily S. Riser, MD (1)  ·  Tracy L Goeken, M.D. (1)